Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration

OBJECTIVE: To compare the efficacy of ranibizumab plus fufang xueshuantong capsule (cFXST) with the efficacy of ranibizumab alone in treatment of exudative age-related macular degeneration. METHODS: This prospective, randomized, controlled, pilot study included 38 eyes from 38 patients with exudativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Hai-Tao, Wang, Jun-Jun, Huang, Jun-Long, Shuai, Yuan-Lu, Li, Jia, Hu, Zi-Zhong, Ding, Yu-Zhi, Liu, Qing-Huai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Prospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520929/
https://www.ncbi.nlm.nih.gov/pubmed/32962487
http://dx.doi.org/10.1177/0300060520931618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520929/
https://www.ncbi.nlm.nih.gov/pubmed/32962487
http://dx.doi.org/10.1177/0300060520931618

Ejemplares similares